Leung RW - Search Results

1

Targeting AXL induces tumor-intrinsic immunogenic response in tyrosine kinase inhibitor-resistant liver cancer.

Xie Y, Wu H, He Y, Liu L, Huang IB, Zhou L, Lin CY, Leung RW, Loh JJ, Lee TK, Ding J, Man K, Ma S, Tong M. Xie Y, et al. Among authors: leung rw. Cell Death Dis. 2024 Feb 3;15(2):110. doi: 10.1038/s41419-024-06493-0. Cell Death Dis. 2024. PMID: 38310091 Free PMC article.

2

EPHB2 Activates β-Catenin to Enhance Cancer Stem Cell Properties and Drive Sorafenib Resistance in Hepatocellular Carcinoma.

Leung HW, Leung CON, Lau EY, Chung KPS, Mok EH, Lei MML, Leung RWH, Tong M, Keng VW, Ma C, Zhao Q, Ng IOL, Ma S, Lee TK. Leung HW, et al. Cancer Res. 2021 Jun 15;81(12):3229-3240. doi: 10.1158/0008-5472.CAN-21-0184. Epub 2021 Apr 26. Cancer Res. 2021. PMID: 33903122

3

Hampering Stromal Cells in the Tumor Microenvironment as a Therapeutic Strategy to Destem Cancer Stem Cells.

Chung KPS, Leung RWH, Lee TKW. Chung KPS, et al. Cancers (Basel). 2021 Jun 25;13(13):3191. doi: 10.3390/cancers13133191. Cancers (Basel). 2021. PMID: 34202411 Free PMC article. Review.

4

UBE2T: A new molecular regulator of cancer stemness in hepatocellular carcinoma.

Leung RWH, Ho NPY, Leung CON, Lee TKW. Leung RWH, et al. Oncotarget. 2021 Aug 17;12(17):1727-1728. doi: 10.18632/oncotarget.28033. eCollection 2021 Aug 17. Oncotarget. 2021. PMID: 34434501 Free PMC article. No abstract available.

5

Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma.

Leung RWH, Lee TKW. Leung RWH, et al. Cancers (Basel). 2022 Nov 7;14(21):5468. doi: 10.3390/cancers14215468. Cancers (Basel). 2022. PMID: 36358885 Free PMC article. Review.

6

SCYL3, as a novel binding partner and regulator of ROCK2, promotes hepatocellular carcinoma progression.

Lei MML, Leung CON, Lau EYT, Leung RWH, Ma VWS, Tong M, Lu YY, Huang CY, Zhu QH, Ng IOL, Ma S, Lee TKW. Lei MML, et al. Among authors: leung rwh. JHEP Rep. 2022 Oct 13;5(1):100604. doi: 10.1016/j.jhepr.2022.100604. eCollection 2023 Jan. JHEP Rep. 2022. PMID: 36440258 Free PMC article.

7

Broad-spectrum kinome profiling identifies CDK6 upregulation as a driver of lenvatinib resistance in hepatocellular carcinoma.

Leung CON, Yang Y, Leung RWH, So KKH, Guo HJ, Lei MML, Muliawan GK, Gao Y, Yu QQ, Yun JP, Ma S, Zhao Q, Lee TKW. Leung CON, et al. Among authors: leung rwh. Nat Commun. 2023 Oct 23;14(1):6699. doi: 10.1038/s41467-023-42360-w. Nat Commun. 2023. PMID: 37872167 Free PMC article.

8

Identification of KCTD17 as a RAS stabilizer in hepatocellular carcinoma.

Leung RWH, Lee TKW. Leung RWH, et al. Clin Mol Hepatol. 2024 Aug 30. doi: 10.3350/cmh.2024.0718. Online ahead of print. Clin Mol Hepatol. 2024. PMID: 39218444 Free article. No abstract available.

9

Effect of a 4-Week Telerehabilitation Program for People With Post-COVID Syndrome on Physical Function and Symptoms: Protocol for a Randomized Controlled Trial.

Reeves JM, Spencer LM, Tsai LL, Baillie AJ, Han Y, Leung RWM, Bishop JA, Troy LK, Corte TJ, Teoh AKY, Peters M, Barton C, Jones L, Alison JA. Reeves JM, et al. Among authors: leung rwm. Phys Ther. 2024 Sep 4;104(9):pzae080. doi: 10.1093/ptj/pzae080. Phys Ther. 2024. PMID: 38943360 Free PMC article. Clinical Trial.

10

Butyrate acts as a positive allosteric modulator of the 5-HT transporter to decrease availability of 5-HT in the ileum.

Cai J, Cheung J, Cheung SWM, Chin KTC, Leung RWK, Lam RST, Sharma R, Yiu JHC, Woo CW. Cai J, et al. Among authors: leung rwk. Br J Pharmacol. 2024 Jun;181(11):1654-1670. doi: 10.1111/bph.16305. Epub 2024 Feb 5. Br J Pharmacol. 2024. PMID: 38129963

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters